EUVIMEDEUVIMED entdecken
Leitlinie

Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines

S Michael Crawford, Colin Evans

Family Practice · 27.03.2018 · 35 (2) · 199-202

DOI: 10.1093/fampra/cmx096 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Family Practice, online erschienen am 28.09.2017. Verfasst von S Michael Crawford und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Office, Airedale NHS Foundation Trust, Keighley, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCA-125 AntigenElectronic Health RecordsFemaleHumansOvarian NeoplasmsPractice Guidelines as TopicPredictive Value of TestsPrimary Health CareUnited Kingdom

Substanzen

Biomarkers, TumorCA-125 Antigen

Autor:innen und Institutionen

  • Research Office, Airedale NHS Foundation Trust, Keighley, UK.

Zitieren

APA

Crawford, S. M., & Evans, C. (2018). Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines. Family Practice, 35(2), 199-202. https://doi.org/10.1093/fampra/cmx096

Vancouver

Crawford SM, Evans C. Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines. Family Practice. 2018;35(2):199-202. doi:10.1093/fampra/cmx096

BibTeX
@article{Crawford2018,
  author = {Crawford, S Michael and Evans, Colin},
  title = {Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines},
  journal = {Family Practice},
  year = {2018},
  volume = {35},
  number = {2},
  pages = {199--202},
  doi = {10.1093/fampra/cmx096}
}
Kostenlos starten →